All In MedTech

Device Trial Radar · NCT07017972

Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model

Multicenter Data Collection and Simulated-Use Assessment for CHLOE

Last checked: Nov 19, 2026Latest source record: Aug 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

4,000

Planned (sponsor's estimate)

Start

Jun 20, 2025

Primary completion

Jun 20, 2027

Study completion Jun 20, 2027

Sponsor

Lead sponsor
FairtilityNot on our public-company list
Sponsor type
Industry
First posted
Jun 12, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-quality real clinical data. It also aims to enhance machine learning in developmental-use AI software. In addition, the professional user simulated use will ensure correct and easy use of the AI applications.

Conditions

  • Fertility Disorders

Interventions

  • AI evaluation of embryosDevice

    AI evaluation of embryos inside a time-lapse incubator.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Area under the curve (AUC) will be quantified using logistic regression to assess EQ Score's prediction of utilization.Time frame: 7 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • New England Fertility Institute

    Stamford, Connecticut · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.